Nadir CD4 T-cell counts continue to influence interferon-? responses in HIV patients who began antiretroviral treatment with advanced immunodeficiency

QR Code

Nadir CD4 T-cell counts continue to influence interferon-? responses in HIV patients who began antiretroviral treatment with advanced immunodeficiency

Bibliographic Details
Main Authors:	Price, Patricia, Fernandez, S., Tan, D., James, I., Keane, N., French, M.
Format:	Journal Article
Published:	Lippincott Williams & Wilkins 2008
Online Access:	http://hdl.handle.net/20.500.11937/30417

Similar Items

Immunosenescent CD57 +CD4+ T-cells accumulate and contribute to interferon-γ responses in HIV patients responding stably to ART
by: Fernandez, S., et al.
Published: (2011)

CD4 + T-cell deficiency in HIV patients responding to antiretroviral therapy is associated with increased expression of interferon-stimulated genes in CD4 + T cells
by: Fernandez, S., et al.
Published: (2011)

Could natural killer cells compensate for impaired CD4+ T-cell responses to CMV in HIV patients responding to antiretroviral therapy?
by: Tan, D., et al.
Published: (2009)

The number and function of circulating dendritic cells may limit effector memory CD4+ T-cell responses in HIV patients responding to antiretroviral therapy
by: Fernandez, S., et al.
Published: (2008)

Polymorphisms in IL10 may alter CD4 T-cell counts in Indonesian HIV patients beginning antiretroviral therapy
by: Dmello, D., et al.
Published: (2017)

CD4+ and CD8+ T cells expressing FoxP3 in HIV-infected patients are phenotypically distinct and influenced by disease severity and antiretroviral therapy
by: Lim, A., et al.
Published: (2009)

Immune restoration disease complicating antiretroviral therapy in patients with HIV infection: Implications and solutions
by: French, M., et al.
Published: (2008)

Impaired Upregulation of the Costimulatory Molecules, CD27 and CD28, on CD4(+) T Cells from HIV Patients Receiving ART Is Associated with Poor Proliferative Responses.
by: Tanaskovic, S., et al.
Published: (2016)

CD56+ lymphocyte counts remain low in the livers of human immunodeficiency virus/hepatitis C virus patients commencing ART
by: Susufi, Y., et al.
Published: (2015)

Robust interferon-a and IL-12 responses by dendritic cells are related to efficient CD4+ T-cell recovery in HIV patients on ART
by: Tan, D., et al.
Published: (2011)

CD31 (PECAM-1) is a marker of recent thymic emigrants among CD4+ T-cells, but not CD8+ T-cells or ? d T-cells, in HIV patients responding to ART
by: Tanaskovic, S., et al.
Published: (2010)

Interleukin-7 signalling defects in naive CD4+ T cells of HIV patients with CD4+ T-cell deficiency onantiretroviral therapy are associated with T-cell activation and senescence
by: Tanaskovic, S., et al.
Published: (2014)

CCR5 polymorphisms and its relationship with HIV susceptibility, viral load and CD4 count in early antiretroviral therapy among HIV patients in Selangor and Terengganu
by: Mohamad Isa, Irma Izani, et al.
Published: (2023)

Editorial: It began with citrus
by: Schreier, P., et al.
Published: (2013)

The dynamics of HCV-specific antibody responses in HIV/HCV patients on long-term antiretroviral therapy
by: Lee, S., et al.
Published: (2017)

The high frequency of autoantibodies in HIV patients declines on antiretroviral therapy
by: Bundell, C., et al.
Published: (2018)

Active and Persistent Cytomegalovirus Infections Affect T Cells in Young Adult HIV Patients Commencing Antiretroviral Therapy
by: Ariyanto, I., et al.
Published: (2018)

The search for biomarkers of immune restoration disease associated with Mycobacterium tuberculosis in HIV patients beginning antiretroviral therapy
by: Oliver, B., et al.
Published: (2011)

Interferon-? and IL-5 production correlate directly in HIV patients Co-infected with mycobacterium tuberculosis with or without immune restoration disease
by: Oliver, B., et al.
Published: (2010)

Patients co-infected with hepatitis C virus (HCV) and human immunodeficiency virus recover genotype cross-reactive neutralising antibodies to HCV during antiretroviral therapy
by: Lee, S., et al.
Published: (2014)

Tuberculosis after commencing antiretroviral therapy for HIV infection is associated with elevated CXCL9 and CXCL10 responses to Mycobacterium tuberculosis antigens.
by: Oliver, B., et al.
Published: (2012)

IL1A alleles associate with a virological response to antiretroviral therapy in HIV patients beginning therapy with advanced disease
by: Price, Patricia, et al.
Published: (2009)

Expansion of adaptive NK cells in HIV disease persists following combination antiretroviral therapy
by: Hearps, A., et al.
Published: (2016)

Immunological and epidemiological factors affecting candidiasis in HIV patients beginning antiretroviral therapy in an Asian clinic
by: Wulandari, E., et al.
Published: (2017)

Do Cytomegalovirus Antibody Levels Associate with Age-Related Syndromes in HIV Patients Stable on Antiretroviral Therapy?
by: Brunt, S., et al.
Published: (2016)

Thymic tissue is not evident on high-resolution computed tomography and [18F]Fluoro-deoxy-glucose positron emission tomography scans of aviraemic HIV patients with poor recovery of CD4 + T cells
by: Tanaskovic, S., et al.
Published: (2011)

Adherence to antiretroviral drug therapy in adult patients who are HIV-positive in Northwest Ethiopia: A study protocol
by: Bezabhe, W., et al.
Published: (2013)

Predictors of adherence to antiretroviral therapy among human immunodeficiency virus patients in Jos University Teaching Hospital, Nigeria
by: Panmial, P. D., et al.
Published: (2019)

Few Liver-Infiltrating Cells Express CXCR3 in HIV/HCV Patients Commencing Antiretroviral Therapy.
by: Marini, S., et al.
Published: (2016)

Pre-antiretroviral therapy plasma levels of CCL2 may aid in the prediction of tuberculosis-associated immune reconstitution inflammatory syndrome in HIV patients after they commence antiretroviral therapy
by: Oliver, B., et al.
Published: (2013)

Naive and Memory CD4+ T Cells Are Differentially Affected in Indonesian HIV Patients Responding to ART
by: Tanaskovic, S., et al.
Published: (2016)

Mediators of innate and adaptive immune responses differentially affect immune restoration disease associated with Mycobacterium tuberculosis in HIV patients beginning antiretroviral therapy
by: Oliver, B., et al.
Published: (2010)

Chemokine receptor expression on dendritic cells is normal in HIV-infected patients with a stable response to ART, but chemokine levels remain elevated
by: Lee, S., et al.
Published: (2011)

Immunopathogenesis of hepatic flare in HIV/hepatitis b virus (Hbv)-coinfected individuals after the initiation of Hbv-active antiretroviral therapy
by: Crane, M., et al.
Published: (2009)

HIV-negative and HIV-positive gay men's attitudes to medicines, HIV treatments and antiretroviral-based prevention
by: Holt, M., et al.
Published: (2013)

Association between belief in medicine and adherence to antiretroviral therapy among human immunodeficiency virus adults in Zaira, Kaduna State, Nigeria
by: Eze, Rosemary A, et al.
Published: (2023)

Persistence of Activated and Adaptive-Like NK Cells in HIV+ Individuals despite 2 Years of Suppressive Combination Antiretroviral Therapy
by: Hearps, A., et al.
Published: (2017)

Increased proportion of the CD56bright NK cell subset in patients chronically infected with Hepatitis C Virus (HCV) receiving interferon-a and ribavirin therapy
by: Lee, S., et al.
Published: (2010)

Mesenteric Lymphatic Targeting of Antiretroviral agents for Improved Treatment of HIV/AIDS
by: Chu, YenJu
Published: (2023)

Short communication: Plasma levels of vitamin D in HIV patients initiating antiretroviral therapy do not predict immune restoration disease associated with mycobacterium tuberculosis
by: Price, Patricia, et al.
Published: (2012)

Cannot write session to /tmp/vufind_sessions/sess_305cnav66v2vgbvsb0beas3o9n